Trials / Completed
CompletedNCT04756362
IN-HOspital Program to systematizE Chest Pain Protocol (IN-HOPE)
Potential Impact in Clinical Practice of Early Exclusion Protocols for Acute Myocardial Infarction With High Sensitivity Troponin T in Different Scenarios (IN-HOspital Program to SystematizE Chest Pain Protocol-IN HOPE)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 5,497 (actual)
- Sponsor
- Hospital Samaritano Paulista · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Multicenter Nationwide Study for Analysis of the Potential Impact in Clinical Practice of Early Exclusion Protocols for Acute Myocardial Infarction with High Sensitivity Troponin T
Detailed description
Chest pain is the main clinical complaint in emergency room visits and represents the most common symptom of Acute Myocardial Infarction, which is the main cause of death in Brazil and worldwide. Although most patients with chest pain do not have a final diagnosis of AMI, they remain under observation until the diagnosis of AMI is excluded. The most current strategy recommended for rapid AMI exclusion uses high-sensitivity cardiac troponin T at time zero and one hour later. However, some points that have not yet been properly evaluated in previous studies can be evaluated in the current study: * Evaluation of the early exclusion protocol (0 -1 hour) in a Brazilian population * Evaluation of the early exclusion protocol (0 -1 hour) in isolation and associated with traditional risk scores (TIMI, GRACE, HEART and EDACS) * Systematic evaluation of the early exclusion protocol (0 -1 hour) in patients without chest pain but with a pre-defined condition of suspected AMI * Evaluation of the prognostic value of an isolated high-sensitivity cardiac troponin T \< 5 ng/L in a diverse population.
Conditions
Timeline
- Start date
- 2020-07-23
- Primary completion
- 2022-01-31
- Completion
- 2022-07-31
- First posted
- 2021-02-16
- Last updated
- 2022-08-03
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT04756362. Inclusion in this directory is not an endorsement.